Sickle cell disease (English Wikipedia)

Elzouki AY (2012). Textbook of clinical pediatrics (2 ed.). Berlin: Springer. p. 2950. ISBN 9783642022012.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on Addressing Sickle Cell Disease (2020). Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action. Washington: National Academies Press. p. 1. ISBN 978-0-309-66960-3.

casgevy.com

"How does Casgevy work?". Vertex Pharmaceuticals Incorporated. 7 December 2024. Retrieved 7 December 2024.

cdc.gov

"Parvovirus B19". Centers for Disease Control and Prevention. 24 August 2023. Retrieved 8 May 2024.
"Complications of Sickle Cell Disease". Centers for Disease Control and Prevention. 22 May 2024. Retrieved 29 October 2024.
"Sickle Cell Disease (SCD): What Is Sickle Cell Trait?". Centers for Disease Control and Prevention. 22 May 2024. Retrieved 7 November 2024.
"Prevention and Treatment of SCD Complications". Centers for Disease Control and Prevention. 3 October 2024. Retrieved 28 November 2024.
"Complications of Sickle Cell Disease". Centers for Disease Control and Prevention. 22 May 2024. Retrieved 5 December 2024.
"Data & Statistics on Sickle Cell Disease". Centers for Disease Control and Prevention. 31 August 2016. Retrieved 13 December 2019.
"September is Sickle Cell Awareness Month". Centers for Disease Control and Prevention. Archived from the original on 27 September 2010. Retrieved 6 February 2011.

clevelandclinic.org

my.clevelandclinic.org

"Sickle Cell Anemia: Symptoms, What It Is, Causes & Treatment". Cleveland Clinic. Retrieved 8 May 2024.
"Sickle Cell Disease". Cleveland Clinic. 3 August 2023. Retrieved 25 October 2024.
"Hematopoiesis". Cleveland Clinic. 12 December 2022. Retrieved 6 December 2024.

doi.org

Thomson AM, McHugh TA, Oron AP, Teply C, Lonberg N, Vilchis Tella V, et al. (August 2023). "Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021". The Lancet. Haematology. 10 (8): e585 – e599. doi:10.1016/S2352-3026(23)00118-7. ISSN 2352-3026. PMC 10390339. PMID 37331373.{{cite journal}}: CS1 maint: overridden setting (link)
Nelson MD, Bennett DM, Lehman ME, Okonji AI (5 December 2022). "Dizziness, Falls, and Hearing Loss in Adults Living With Sickle Cell Disease". American Journal of Audiology. 31 (4): 1178–1190. doi:10.1044/2022_AJA-22-00059. ISSN 1558-9137. PMID 36251873.
Wilkinson E (16 November 2023). "UK regulator approves "groundbreaking" gene treatment for sickle cell and β thalassaemia". BMJ. 383: 2706. doi:10.1136/bmj.p2706. ISSN 1756-1833. PMID 37973171. S2CID 265264939.
Singh A, Irfan H, Fatima E, Nazir Z, Verma A, Akilimali A (15 May 2024). "Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease". Annals of Medicine and Surgery. 86 (8): 4555. doi:10.1097/MS9.0000000000002146. PMC 11305803. PMID 39118728.
Rees DC, Williams TN, Gladwin MT (December 2010). "Sickle-cell disease". Lancet. 376 (9757): 2018–2031. doi:10.1016/s0140-6736(10)61029-x. PMID 21131035. S2CID 29909566.
Savitt TL, Goldberg MF (January 1989). "Herrick's 1910 case report of sickle cell anemia. The rest of the story". The Journal of the American Medical Association. 261 (2): 266–271. doi:10.1001/jama.261.2.266. PMID 2642320.
Serjeant GR (December 2010). "One hundred years of sickle cell disease". British Journal of Haematology. 151 (5): 425–429. doi:10.1111/j.1365-2141.2010.08419.x. PMID 20955412.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. (September 2014). "Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members". The Journal of the American Medical Association. 312 (10): 1033–1048. doi:10.1001/jama.2014.10517. PMID 25203083. S2CID 37681044.
Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. (15 July 1995). "Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease [see comments]". Blood. 86 (2): 776–783. doi:10.1182/blood.v86.2.776.bloodjournal862776. ISSN 0006-4971.
Olujohungbe A, Burnett AL (March 2013). "How I manage priapism due to sickle cell disease". British Journal of Haematology. 160 (6): 754–765. doi:10.1111/bjh.12199. PMID 23293942.
Shah P, Khaleel M, Thuptimdang W, Sunwoo J, Veluswamy S, Chalacheva P, et al. (1 January 2020). "Mental stress causes vasoconstriction in subjects with sickle cell disease and in normal controls". Haematologica. 105 (1): 83–90. doi:10.3324/haematol.2018.211391. ISSN 1592-8721. PMC 6939522. PMID 30975906.
Brousse V, Buffet P, Rees D (1 July 2014). "The spleen and sickle cell disease: the sick(led) spleen". British Journal of Haematology. 166 (2): 165–176. doi:10.1111/bjh.12950. ISSN 1365-2141. PMID 24862308. S2CID 40448991.
Paul RN, Castro OL, Aggarwal A, Oneal PA (September 2011). "Acute chest syndrome: sickle cell disease". European Journal of Haematology. 87 (3): 191–207. doi:10.1111/j.1600-0609.2011.01647.x. PMID 21615795. S2CID 40320701.
Slavov SN, Kashima S, Pinto AC, Covas DT (August 2011). "Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions". FEMS Immunology and Medical Microbiology. 62 (3): 247–262. doi:10.1111/j.1574-695X.2011.00819.x. PMID 21585562.
Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ (December 2011). "Management of children with sickle cell disease: a comprehensive review of the literature". Pediatrics. 128 (6): e1552 – e1574. doi:10.1542/peds.2010-3686. PMID 22123880. S2CID 14524078. Archived from the original on 4 March 2016.
Adams RJ, Ohene-Frempong K, Wang W (2001). "Sickle cell and the brain". Hematology. American Society of Hematology. Education Program. 2001 (1): 31–46. doi:10.1182/asheducation-2001.1.31. PMID 11722977.
Adams RJ (November 2007). "Big strokes in small persons". Archives of Neurology. 64 (11): 1567–1574. doi:10.1001/archneur.64.11.1567. PMID 17998439.
Martí-Carvajal AJ, Solà I, Agreda-Pérez LH (December 2019). "Treatment for avascular necrosis of bone in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 2019 (12): CD004344. doi:10.1002/14651858.CD004344.pub7. PMC 6894369. PMID 31803937.
Chrouser KL, Ajiboye OB, Oyetunji TA, Chang DC (April 2011). "Priapism in the United States: the changing role of sickle cell disease". American Journal of Surgery. 201 (4): 468–474. doi:10.1016/j.amjsurg.2010.03.017. PMID 21421100.
Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, et al. (October 1991). "Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality". Annals of Internal Medicine. 115 (8): 614–620. doi:10.7326/0003-4819-115-8-614. PMID 1892333.
Saborio P, Scheinman JI (January 1999). "Sickle Cell Nephropathy". Journal of the American Society of Nephrology. 10 (1): 187–192. doi:10.1681/ASN.V101187. ISSN 1046-6673. PMID 9890326.
Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK (October 2010). "Leg ulcers in sickle cell disease". American Journal of Hematology. 85 (10): 831–833. doi:10.1002/ajh.21838. ISSN 0361-8609. PMC 2953786. PMID 20872960.
Elagouz M, Jyothi S, Gupta B, Sivaprasad S (July 2010). "Sickle cell disease and the eye: old and new concepts". Survey of Ophthalmology. 55 (4): 359–377. doi:10.1016/j.survophthal.2009.11.004. PMID 20452638.
Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. (January 2008). "Daily assessment of pain in adults with sickle cell disease". Annals of Internal Medicine. 148 (2): 94–101. CiteSeerX 10.1.1.690.5870. doi:10.7326/0003-4819-148-2-200801150-00004. PMID 18195334. S2CID 34924760.
Lai YC, Potoka KC, Champion HC, Mora AL, Gladwin MT (June 2014). "Pulmonary arterial hypertension: the clinical syndrome". Circulation Research. 115 (1): 115–130. doi:10.1161/CIRCRESAHA.115.301146. PMC 4096686. PMID 24951762.
Caughey MC, Poole C, Ataga KI, Hinderliter AL (August 2015). "Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review". British Journal of Haematology. 170 (3): 416–424. doi:10.1111/bjh.13447. PMID 25854714. S2CID 23920740.
Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, et al. (March 2016). "Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease". JACC. Cardiovascular Imaging. 9 (3): 243–252. doi:10.1016/j.jcmg.2015.05.013. PMC 4788530. PMID 26897687.
Niss O, Fleck R, Makue F, Alsaied T, Desai P, Towbin JA, et al. (July 2017). "Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia". Blood. 130 (2): 205–213. doi:10.1182/blood-2017-02-767624. PMC 5510791. PMID 28507082.
Rai P, Niss O, Malik P (November 2017). "A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia". Pediatric Blood & Cancer. 64 (11): e26607. doi:10.1002/pbc.26607. PMID 28453224. S2CID 24444332.
Sankaran VG, Orkin SH (January 2013). "The switch from fetal to adult hemoglobin". Cold Spring Harbor Perspectives in Medicine. 3 (1): a011643. doi:10.1101/cshperspect.a011643. PMC 3530042. PMID 23209159.
Green NS, Fabry ME, Kaptue-Noche L, Nagel RL (October 1993). "Senegal haplotype is associated with higher HbF than Benin and Cameroon haplotypes in African children with sickle cell anemia". American Journal of Hematology. 44 (2): 145–146. doi:10.1002/ajh.2830440214. PMID 7505527. S2CID 27341091.
Inusa BP, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, et al. (June 2019). "Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment". International Journal of Neonatal Screening. 5 (2): 20. doi:10.3390/ijns5020020. ISSN 2409-515X. PMC 7510211. PMID 33072979.
Odièvre MH, Verger E, Silva-Pinto AC, Elion J (October 2011). "Pathophysiological insights in sickle cell disease". The Indian Journal of Medical Research. 134 (1): 532–537. doi:10.1007/bf00168807. PMC 3237253. PMID 22089617.
Uyoga S, Olupot-Olupot P, Connon R, Kiguli S, Opoka RO, Alaroker F, et al. (September 2022). "Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT)". The Lancet Child & Adolescent Health. 6 (9): 606–613. doi:10.1016/s2352-4642(22)00153-5. ISSN 2352-4642. PMC 7613576. PMID 35785794.
Luzzatto L (3 October 2012). "Sickle Cell Anaemia and Malaria". Mediterranean Journal of Hematology and Infectious Diseases. 4 (1): e2012065. doi:10.4084/mjhid.2012.065. ISSN 2035-3006. PMC 3499995. PMID 23170194.
Kwiatkowski DP (August 2005). "How malaria has affected the human genome and what human genetics can teach us about malaria". American Journal of Human Genetics. 77 (2): 171–192. doi:10.1086/432519. PMC 1224522. PMID 16001361.
Ponçon N, Toty C, L'Ambert G, Le Goff G, Brengues C, Schaffner F, et al. (February 2007). "Biology and dynamics of potential malaria vectors in Southern France". Malaria Journal. 6 (1): 18. doi:10.1186/1475-2875-6-18. PMC 1808464. PMID 17313664.
Arif SH (19 March 2008). "Sickle cell disease and malaria". Indian Journal of Hematology & Blood Transfusion. 23 (3–4): 70–72. doi:10.1007/s12288-008-0001-3. PMC 3453113. PMID 23100918.
Cao H, Antonopoulos A, Henderson S, Wassall H, Brewin J, Masson A, et al. (19 March 2021). "Red blood cell mannoses as phagocytic ligands mediating both sickle cell anaemia and malaria resistance". Nature Communications. 12 (1): 1792. Bibcode:2021NatCo..12.1792C. doi:10.1038/s41467-021-21814-z. ISSN 2041-1723. PMC 7979802. PMID 33741926.
Padilla F, Bromberg PA, Jensen WN (1 May 1973). "The Sickle-Unsickle Cycle: A Cause of Cell Fragmentation Leading to Permanently Deformed Cells". Blood. 41 (5): 653–660. doi:10.1182/blood.V41.5.653.653. ISSN 0006-4971. PMID 4694082.
Gbotosho OT, Kapetanaki MG, Kato GJ (27 January 2021). "The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease". Frontiers in Immunology. 11. doi:10.3389/fimmu.2020.561917. ISSN 1664-3224. PMC 7873693. PMID 33584641.
Sundd P, Gladwin MT, Novelli EM (24 January 2019). "Pathophysiology of Sickle Cell Disease". Annual Review of Pathology: Mechanisms of Disease. 14 (1): 263–292. doi:10.1146/annurev-pathmechdis-012418-012838. ISSN 1553-4006. PMC 7053558. PMID 30332562.
Arishi WA, Alhadrami HA, Zourob M (5 May 2021). "Techniques for the Detection of Sickle Cell Disease: A Review". Micromachines. 12 (5): 519. doi:10.3390/mi12050519. PMC 8148117. PMID 34063111.
Mendez-Marti SR, Zik C, Alan S, Wang H, Ershler WB (June 2024). "Sickle Cell Screening in Adults: A Current Review of Point-of-Care Testing". Journal of Hematology. 13 (3): 53–60. doi:10.14740/jh1272. ISSN 1927-1212. PMC 11236353. PMID 38993742.
Garfin DE (1990), Deutscher MP (ed.), "[35] Isoelectric focusing", Methods in Enzymology, Guide to Protein Purification, 182, Academic Press: 459–477, doi:10.1016/0076-6879(90)82037-3, ISBN 978-0-12-182083-1, PMID 2314254, retrieved 20 November 2024
Dixit R, Nettem S, Madan SS, Soe HH, Abas AB, Vance LD, et al. (March 2018). "Folate supplementation in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 3 (4): CD011130. doi:10.1002/14651858.CD011130.pub3. PMC 5440187. PMID 29546732.
Obeagu EI, Obeagu GU (20 September 2024). "Immunization strategies for individuals with sickle cell anemia: A narrative review". Medicine. 103 (38): e39756. doi:10.1097/MD.0000000000039756. PMC 11419550. PMID 39312357.
Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, et al. (April 2003). "Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment". The Journal of the American Medical Association. 289 (13): 1645–1651. doi:10.1001/jama.289.13.1645. PMID 12672732.
Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. (May 1995). "Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia". The New England Journal of Medicine. 332 (20): 1317–1322. doi:10.1056/NEJM199505183322001. PMID 7715639.
McGann P, Ware R (14 September 2015). "Hydroxyurea therapy for sickle cell anemia". Expert Opinion in Drug Safety. 14 (11): 1749–1758. doi:10.1517/14740338.2015.1088827. PMC 5868345. PMID 26366626.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. (September 2014). "Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members". The Journal of the American Medical Association. 312 (10): 1033–1048. doi:10.1001/jama.2014.10517. PMID 25203083. S2CID 37681044.
Platt OS (March 2008). "Hydroxyurea for the treatment of sickle cell anemia". The New England Journal of Medicine. 358 (13): 1362–1369. doi:10.1056/NEJMct0708272. PMID 18367739. S2CID 351061.
Rankine-Mullings AE, Nevitt SJ (September 2022). "Hydroxyurea (hydroxycarbamide) for sickle cell disease". The Cochrane Database of Systematic Reviews. 2022 (10): CD002202. doi:10.1002/14651858.CD002202.pub3. PMC 9435593. PMID 36047926.
Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, et al. (August 2019). "A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease". The New England Journal of Medicine. 381 (6): 509–519. doi:10.1056/NEJMoa1903212. PMID 31199090.
Han H, Hensch L, Tubman VN (10 December 2021). "Indications for transfusion in the management of sickle cell disease". Hematology. 2021 (1): 696–703. doi:10.1182/hematology.2021000307. ISSN 1520-4391. PMC 8791131. PMID 34889416.
Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. (July 1998). "Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography". The New England Journal of Medicine. 339 (1): 5–11. doi:10.1056/NEJM199807023390102. PMID 9647873.
Gyang E, Yeom K, Hoppe C, Partap S, Jeng M (January 2011). "Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease". American Journal of Hematology. 86 (1): 104–106. doi:10.1002/ajh.21901. PMID 21117059.
Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, et al. (March 2010). "Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease". European Journal of Haematology. 84 (3): 259–265. doi:10.1111/j.1600-0609.2009.01379.x. PMID 19912310. S2CID 24316310.
Anie KA, Green J (May 2015). "Psychological therapies for sickle cell disease and pain". The Cochrane Database of Systematic Reviews. 2015 (5): CD001916. doi:10.1002/14651858.CD001916.pub3. PMC 7063720. PMID 25966336.
Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, et al. (August 1996). "Bone marrow transplantation for sickle cell disease". The New England Journal of Medicine. 335 (6): 369–376. doi:10.1056/NEJM199608083350601. PMID 8663884. S2CID 25256772.
Olson TS, Walters MC (1 October 2023). "Allogeneic haematopoietic stem-cell transplantation versus gene therapy for haemoglobinopathies". The Lancet Haematology. 10 (10): e798 – e800. doi:10.1016/S2352-3026(23)00246-6. ISSN 2352-3026. PMID 37793770.
Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, et al. (2 March 2017). "Gene Therapy in a Patient with Sickle Cell Disease". New England Journal of Medicine. 376 (9): 848–855. doi:10.1056/NEJMoa1609677. ISSN 0028-4793. PMID 28249145.
Rotin LE, Viswabandya A, Kumar R, Patriquin CJ, Kuo KH (31 December 2023). "A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease". Hematology. 28 (1). doi:10.1080/16078454.2022.2163357. ISSN 1607-8454. PMID 36728286.
Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN (1 December 2011). "Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality". American Journal of Preventive Medicine. 41 (6): S398 – S405. doi:10.1016/j.amepre.2011.09.013. ISSN 0749-3797. PMC 3708126. PMID 22099364.
Karkoska K, McGann PT (2 November 2023). "Changing Trends in Sickle Cell Disease-Related Mortality in the United States over Four Decades". Blood. 142 (Supplement 1): 925. doi:10.1182/blood-2023-177988. ISSN 0006-4971.
Roberts I, de Montalembert M (July 2007). "Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe". Haematologica. 92 (7): 865–871. doi:10.3324/haematol.11474. PMID 17606434.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Wellems TE, Hayton K, Fairhurst RM (September 2009). "The impact of malaria parasitism: from corpuscles to communities". The Journal of Clinical Investigation. 119 (9): 2496–2505. doi:10.1172/JCI38307. PMC 2735907. PMID 19729847.
Tusuubira SK, Nakayinga R, Mwambi B, Odda J, Kiconco S, Komuhangi A (April 2018). "Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda". BMC Public Health. 18 (1): 561. doi:10.1186/s12889-018-5496-4. PMC 5924488. PMID 29703184.
Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, et al. (March 2016). "Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study". The Lancet. Global Health. 4 (3): e195 – e200. doi:10.1016/S2214-109X(15)00288-0. PMID 26833239.
Edwards QT, Seibert D, Macri C, Covington C, Tilghman J (November 2004). "Assessing ethnicity in preconception counseling: genetics—what nurse practitioners need to know". Journal of the American Academy of Nurse Practitioners. 16 (11): 472–480. doi:10.1111/j.1745-7599.2004.tb00426.x. PMID 15617360. S2CID 7644129.
Vlachadis N, Vrachnis N (15 November 2022). "A Review of Sickle Cell Disease". JAMA. 328 (19): 1979. doi:10.1001/jama.2022.16732. ISSN 0098-7484. PMID 36378213.
Beillat M, Durand-Zaleski I, Pirenne F, Bénard S, Chillotti L, Galacteros F (21 September 2023). "Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires". Frontiers in Public Health. 11: 1215605. doi:10.3389/fpubh.2023.1215605. PMC 10552641. PMID 37808997.
Thuret I, Sarles J, Merono F, Suzineau E, Collomb J, Lena-Russo D, et al. (June 2010). "Neonatal screening for sickle cell disease in France: evaluation of the selective process". Journal of Clinical Pathology. 63 (6): 548–551. doi:10.1136/jcp.2009.068874. PMID 20498028. S2CID 22391674.
Jastaniah W (2011). "Epidemiology of sickle cell disease in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 289–293. doi:10.4103/0256-4947.81540. PMC 3119971. PMID 21623060.
Memish ZA, Saeedi MY (2011). "Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 229–235. doi:10.4103/0256-4947.81527. PMC 3119961. PMID 21623050.
Al Arrayed S, Al Hajeri A (2010). "Public awareness of sickle cell disease in Bahrain". Annals of Saudi Medicine. 30 (4): 284–288. doi:10.4103/0256-4947.65256. PMC 2931779. PMID 20622345.
Awasthy N, Aggarwal KC, Goyal PC, Prasad MS, Saluja S, Sharma M (2008). "Sickle cell disease: Experience of a tertiary care center in a nonendemic area". Annals of Tropical Medicine and Public Health. 1 (1): 1–4. doi:10.4103/1755-6783.43069 (inactive 1 November 2024).{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
Asnani MR, McCaw-Binns AM, Reid ME (2011). "Excess risk of maternal death from sickle cell disease in Jamaica: 1998–2007". PLOS ONE. 6 (10): e26281. Bibcode:2011PLoSO...626281A. doi:10.1371/journal.pone.0026281. PMC 3200316. PMID 22039456.
Ballas SK, Gupta K, Adams-Graves P (November 2012). "Sickle cell pain: a critical reappraisal". Blood. 120 (18): 3647–3656. doi:10.1182/blood-2012-04-383430. PMID 22923496.
Herrick JB (1 November 1910). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia". Archives of Internal Medicine. 6 (5): 179–184. doi:10.1001/archinte.1910.00050330050003.; reprinted as Herrick JB (2001). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910". The Yale Journal of Biology and Medicine. 74 (3): 179–184. PMC 2588723. PMID 11501714.
Mason VR (1922). "Sickle cell anemia". The Journal of the American Medical Association. 79 (16): 1318–1320. doi:10.1001/jama.1922.02640160038012. Reprinted in Mason VR (October 1985). "Landmark article Oct. 14, 1922: Sickle cell anemia. By V.R. Mason". The Journal of the American Medical Association. 254 (14): 1955–1957. doi:10.1001/jama.254.14.1955. PMID 3900438.
Pauling L, Itano HA (November 1949). "Sickle cell anemia a molecular disease". Science. 110 (2865): 543–548. Bibcode:1949Sci...110..543P. doi:10.1126/science.110.2865.543. PMID 15395398. S2CID 31674765.
Ingram VM (October 1956). "A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin". Nature. 178 (4537): 792–794. Bibcode:1956Natur.178..792I. doi:10.1038/178792a0. PMID 13369537. S2CID 4167855.
Srikanthan S (2023). "Contested Disability: Sickle Cell Disease". Health & Social Work. 48 (3): 209–216. doi:10.1093/hsw/hlad014. PMID 37315205.
Bulgin D, Tanabe P, Jenerette C (August 2018). "Stigma of Sickle Cell Disease: A Systematic Review". Issues in Mental Health Nursing. 39 (8): 675–686. doi:10.1080/01612840.2018.1443530. PMC 6186193. PMID 29652215.
Tusuubira SK, Naggawa T, Nakamoga V (October 2019). "To Join Or Not To Join? A Case Of Sickle Cell Clubs, Stigma And Discrimination In Secondary Schools In Butambala District, Uganda". Adolescent Health, Medicine and Therapeutics. 10: 145–152. doi:10.2147/AHMT.S223956. PMC 6778728. PMID 31632168.
Okwi AL, Byarugaba W, Ndugwa CM, Parkes A, Ocaido M, Tumwine JK (September 2009). "Knowledge gaps, attitude and beliefs of the communities about sickle cell disease in Eastern and Western Uganda". East African Medical Journal. 86 (9): 442–449. doi:10.4314/eamj.v86i9.54167. PMID 21644415.
Marsh VM, Kamuya DM, Molyneux SS (August 2011). "'All her children are born that way': gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya". Ethnicity & Health. 16 (4–5): 343–359. doi:10.1080/13557858.2010.541903. PMC 3534410. PMID 21797722.
Sehlo MG, Kamfar HZ (April 2015). "Depression and quality of life in children with sickle cell disease: the effect of social support". BMC Psychiatry. 15 (1): 78. doi:10.1186/s12888-015-0461-6. PMC 4394397. PMID 25880537.

dx.doi.org

Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. (15 July 1995). "Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease [see comments]". Blood. 86 (2): 776–783. doi:10.1182/blood.v86.2.776.bloodjournal862776. ISSN 0006-4971.

elsevier.com

linkinghub.elsevier.com

Garfin DE (1990), Deutscher MP (ed.), "[35] Isoelectric focusing", Methods in Enzymology, Guide to Protein Purification, 182, Academic Press: 459–477, doi:10.1016/0076-6879(90)82037-3, ISBN 978-0-12-182083-1, PMID 2314254, retrieved 20 November 2024
Olson TS, Walters MC (1 October 2023). "Allogeneic haematopoietic stem-cell transplantation versus gene therapy for haemoglobinopathies". The Lancet Haematology. 10 (10): e798 – e800. doi:10.1016/S2352-3026(23)00246-6. ISSN 2352-3026. PMID 37793770.

england.nhs.uk

"NHS launches lifesaving sickle cell campaign". 7 October 2022.

europa.eu

ema.europa.eu

"New treatment for sickle cell disease". European Medicines Agency (RMA) (Press release). 17 December 2021. Retrieved 18 December 2021.
"EMA recommends suspension of sickle cell disease medicine Oxbryta | European Medicines Agency (EMA)". www.ema.europa.eu. 26 September 2024. Retrieved 11 October 2024.
"Adakveo - referral | European Medicines Agency (EMA)". www.ema.europa.eu. 26 May 2023. Retrieved 5 December 2024.

fda.gov

"FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease". U.S. Food and Drug Administration (FDA). 8 December 2023. Archived from the original on 8 December 2023. Retrieved 8 December 2023. This article incorporates text from this source, which is in the public domain.
Center for Drug Evaluation and Research (25 November 2019). "FDA approves voxelotor for sickle cell disease". FDA. Retrieved 9 December 2019.
Research Cf (26 September 2024). "FDA is alerting patients and health care professionals about the voluntary withdrawal of Oxbryta from the market due to safety concerns". FDA.
"FDA approves crizanlizumab-tmca for sickle cell disease". U.S. Food and Drug Administration. 15 November 2019. Retrieved 12 December 2023.

fofweb.com

"Foster, Gloria". Facts On File History Database. Archived from the original on 5 March 2016. Retrieved 25 February 2015.

gov.uk

"MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia". GOV.UK. Retrieved 7 December 2024.
"MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia". Medicines and Healthcare products Regulatory Agency (MHRA) (Press release). 16 November 2023. Archived from the original on 25 November 2023. Retrieved 8 December 2023.

gpo.gov

"Federal Register, Volume 82 Issue 178 (Friday, September 15, 2017)". U.S. Government Publishing Office (GPO). Retrieved 15 January 2018.

guysandstthomas.nhs.uk

"Simple blood transfusion - Overview". Guy's and St Thomas' NHS Foundation Trust. Retrieved 1 December 2024.
"Exchange blood transfusion - Overview". Guy's and St Thomas' NHS Foundation Trust. Retrieved 1 December 2024.

haematologica.org

Shah P, Khaleel M, Thuptimdang W, Sunwoo J, Veluswamy S, Chalacheva P, et al. (1 January 2020). "Mental stress causes vasoconstriction in subjects with sickle cell disease and in normal controls". Haematologica. 105 (1): 83–90. doi:10.3324/haematol.2018.211391. ISSN 1592-8721. PMC 6939522. PMID 30975906.

harvard.edu

ui.adsabs.harvard.edu

Cao H, Antonopoulos A, Henderson S, Wassall H, Brewin J, Masson A, et al. (19 March 2021). "Red blood cell mannoses as phagocytic ligands mediating both sickle cell anaemia and malaria resistance". Nature Communications. 12 (1): 1792. Bibcode:2021NatCo..12.1792C. doi:10.1038/s41467-021-21814-z. ISSN 2041-1723. PMC 7979802. PMID 33741926.
Asnani MR, McCaw-Binns AM, Reid ME (2011). "Excess risk of maternal death from sickle cell disease in Jamaica: 1998–2007". PLOS ONE. 6 (10): e26281. Bibcode:2011PLoSO...626281A. doi:10.1371/journal.pone.0026281. PMC 3200316. PMID 22039456.
Pauling L, Itano HA (November 1949). "Sickle cell anemia a molecular disease". Science. 110 (2865): 543–548. Bibcode:1949Sci...110..543P. doi:10.1126/science.110.2865.543. PMID 15395398. S2CID 31674765.
Ingram VM (October 1956). "A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin". Nature. 178 (4537): 792–794. Bibcode:1956Natur.178..792I. doi:10.1038/178792a0. PMID 13369537. S2CID 4167855.

sickle.bwh.harvard.edu

"Hemoglobinopathies". Brigham and Women's Hospital. April 2002. Retrieved 7 November 2024.
"How Does Sickle Cell Cause Disease?". Archived from the original on 23 September 2010. Retrieved 27 November 2010.

healthdata.org

"Sickle cell disorders - Level 4 cause". Institute for Health Metrics and Evaluation. Retrieved 17 December 2024.

healthlinkbc.ca

"Blood Transfusions for Sickle Cell Disease | HealthLink BC". www.healthlinkbc.ca. Retrieved 8 May 2024.

hematology.org

"Sickle Cell Trait". American Society of Hematology. 8 September 2017. Retrieved 13 December 2019.
"Sickle Cell Anemia". American Society of Hematology. 16 December 2014. Archived from the original on 25 June 2017. Retrieved 1 May 2017.

hsj.co.uk

"London Eye: Shouldn't need an improvement programme". Health Service Journal. 27 July 2022. Retrieved 28 September 2022.^{[need quotation to verify]}

jamanetwork.com

Vlachadis N, Vrachnis N (15 November 2022). "A Review of Sickle Cell Disease". JAMA. 328 (19): 1979. doi:10.1001/jama.2022.16732. ISSN 0098-7484. PMID 36378213.

jefferson.edu

jdc.jefferson.edu

Ballas SK, Gupta K, Adams-Graves P (November 2012). "Sickle cell pain: a critical reappraisal". Blood. 120 (18): 3647–3656. doi:10.1182/blood-2012-04-383430. PMID 22923496.

kidshealth.org

Pitone ML (July 2023). "What's the Connection Between Sickle Cell Trait and Malaria? (for Teens)". kidshealth.org. Retrieved 31 October 2024.

lecturio.com

"Cholelithiasis". The Lecturio Medical Concept Library. Retrieved 25 August 2021.

libretexts.org

bio.libretexts.org

"5.21: Natural Selection". Biology LibreTexts. 23 September 2016. Retrieved 31 October 2024.

lww.com

journals.lww.com

Saborio P, Scheinman JI (January 1999). "Sickle Cell Nephropathy". Journal of the American Society of Nephrology. 10 (1): 187–192. doi:10.1681/ASN.V101187. ISSN 1046-6673. PMID 9890326.

medicalnewstoday.com

Morales-Brown L (9 February 2024). "What is the connection between sickle cell anemia and malaria?". www.medicalnewstoday.com. Retrieved 31 October 2024.

medlineplus.gov

"Sickle cell disease: MedlinePlus Genetics". National Library of Medicine. Retrieved 13 November 2024.
"Hemoglobin Electrophoresis: MedlinePlus Medical Test". medlineplus.gov. Retrieved 20 November 2024.

medscape.com

emedicine.medscape.com

Maakaron JE (25 September 2024). "Sickle Cell Disease (SCD): Overview". Medscape.
"Sickle Cell Disease (SCD) Clinical Presentation: History, Physical Examination". emedicine.medscape.com. Retrieved 5 December 2024.

mjhid.org

Luzzatto L (3 October 2012). "Sickle Cell Anaemia and Malaria". Mediterranean Journal of Hematology and Infectious Diseases. 4 (1): e2012065. doi:10.4084/mjhid.2012.065. ISSN 2035-3006. PMC 3499995. PMID 23170194.

ms.gov

msdh.ms.gov

"Penicillin in Sickle Cell Disease: Quick Facts For Parents". Mississippi State Department of Health. Retrieved 29 November 2024.

mskcc.org

"Facts About Blood and Blood Cells". Memorial Sloan Kettering Cancer Center. 17 December 2021. Retrieved 11 November 2024.

nature.com

"Sickle-Cell Anemia: Haplotype | Learn Science at Scitable". www.nature.com. Retrieved 12 October 2023.

nejm.org

Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, et al. (2 March 2017). "Gene Therapy in a Patient with Sickle Cell Disease". New England Journal of Medicine. 376 (9): 848–855. doi:10.1056/NEJMoa1609677. ISSN 0028-4793. PMID 28249145.

nepalitimes.com

"Life with sickle cell – Nation – Nepali Times". Archived from the original on 24 June 2015.

newbornscreening.info

"Disorder Name: Sickle Cell Disease". New Born Screening. Archived from the original on 28 September 2016. Retrieved 11 October 2016.

nhs.uk

"Sickle cell disease - Symptoms". nhs.uk. 23 October 2017. Retrieved 25 October 2024.
"Sickle cell disease - Causes". National Health Service. 23 October 2017. Retrieved 7 November 2024.
"Newborn blood spot test". National Health Service. 5 September 2024. Retrieved 20 November 2024.
"Sickle cell disease - Carriers". nhs.uk. 23 October 2017. Retrieved 22 November 2024.
"Living with Sickle cell disease". National Health Service. 30 November 2022. Retrieved 28 November 2024.
"Sickle cell disease - Treatment". National Health Service. 23 October 2017. Retrieved 5 December 2024.
"Stem cell transplant - What happens". nhs.uk. 23 October 2017. Retrieved 7 December 2024.
"Inheriting sickle cell anaemia – Live Well – NHS Choices". www.nhs.uk. 23 October 2017. Archived from the original on 2 December 2014.
"Sickle cell anaemia – NHS Choices". www.nhs.uk. 23 October 2017. Archived from the original on 13 December 2011.

nice.org.uk

cks.nice.org.uk

"Sickle cell disease: What is the prognosis?". National Institute for Health and Care Excellence. July 2021. Retrieved 25 October 2024.
"Sickle cell disease: Scenario: Prevention of complications". National Institute for Health and Care Excellence. July 2021. Retrieved 28 November 2024.
"Scenario: Management - sickle cell crisis". National Institute for Health and Care Excellence. July 2021. Retrieved 5 December 2024.
"Sickle cell disease: What is the prognosis?". National Institute for Health and Care Excellence. July 2021. Retrieved 25 October 2024.

nih.gov

pubmed.ncbi.nlm.nih.gov

Thomson AM, McHugh TA, Oron AP, Teply C, Lonberg N, Vilchis Tella V, et al. (August 2023). "Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021". The Lancet. Haematology. 10 (8): e585 – e599. doi:10.1016/S2352-3026(23)00118-7. ISSN 2352-3026. PMC 10390339. PMID 37331373.{{cite journal}}: CS1 maint: overridden setting (link)
Nelson MD, Bennett DM, Lehman ME, Okonji AI (5 December 2022). "Dizziness, Falls, and Hearing Loss in Adults Living With Sickle Cell Disease". American Journal of Audiology. 31 (4): 1178–1190. doi:10.1044/2022_AJA-22-00059. ISSN 1558-9137. PMID 36251873.
Wilkinson E (16 November 2023). "UK regulator approves "groundbreaking" gene treatment for sickle cell and β thalassaemia". BMJ. 383: 2706. doi:10.1136/bmj.p2706. ISSN 1756-1833. PMID 37973171. S2CID 265264939.
Singh A, Irfan H, Fatima E, Nazir Z, Verma A, Akilimali A (15 May 2024). "Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease". Annals of Medicine and Surgery. 86 (8): 4555. doi:10.1097/MS9.0000000000002146. PMC 11305803. PMID 39118728.
Rees DC, Williams TN, Gladwin MT (December 2010). "Sickle-cell disease". Lancet. 376 (9757): 2018–2031. doi:10.1016/s0140-6736(10)61029-x. PMID 21131035. S2CID 29909566.
Savitt TL, Goldberg MF (January 1989). "Herrick's 1910 case report of sickle cell anemia. The rest of the story". The Journal of the American Medical Association. 261 (2): 266–271. doi:10.1001/jama.261.2.266. PMID 2642320.
Serjeant GR (December 2010). "One hundred years of sickle cell disease". British Journal of Haematology. 151 (5): 425–429. doi:10.1111/j.1365-2141.2010.08419.x. PMID 20955412.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. (September 2014). "Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members". The Journal of the American Medical Association. 312 (10): 1033–1048. doi:10.1001/jama.2014.10517. PMID 25203083. S2CID 37681044.
Olujohungbe A, Burnett AL (March 2013). "How I manage priapism due to sickle cell disease". British Journal of Haematology. 160 (6): 754–765. doi:10.1111/bjh.12199. PMID 23293942.
Shah P, Khaleel M, Thuptimdang W, Sunwoo J, Veluswamy S, Chalacheva P, et al. (1 January 2020). "Mental stress causes vasoconstriction in subjects with sickle cell disease and in normal controls". Haematologica. 105 (1): 83–90. doi:10.3324/haematol.2018.211391. ISSN 1592-8721. PMC 6939522. PMID 30975906.
Brousse V, Buffet P, Rees D (1 July 2014). "The spleen and sickle cell disease: the sick(led) spleen". British Journal of Haematology. 166 (2): 165–176. doi:10.1111/bjh.12950. ISSN 1365-2141. PMID 24862308. S2CID 40448991.
Kane I, Kumar A, Atalla E, Nagalli S (5 June 2023), "Splenic Sequestration Crisis", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31985957, retrieved 28 October 2024
Paul RN, Castro OL, Aggarwal A, Oneal PA (September 2011). "Acute chest syndrome: sickle cell disease". European Journal of Haematology. 87 (3): 191–207. doi:10.1111/j.1600-0609.2011.01647.x. PMID 21615795. S2CID 40320701.
Friend A, Settelmeyer TP, Girzadas D (25 November 2023), "Acute Chest Syndrome", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28722902, retrieved 27 October 2024
Slavov SN, Kashima S, Pinto AC, Covas DT (August 2011). "Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions". FEMS Immunology and Medical Microbiology. 62 (3): 247–262. doi:10.1111/j.1574-695X.2011.00819.x. PMID 21585562.
Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ (December 2011). "Management of children with sickle cell disease: a comprehensive review of the literature". Pediatrics. 128 (6): e1552 – e1574. doi:10.1542/peds.2010-3686. PMID 22123880. S2CID 14524078. Archived from the original on 4 March 2016.
Adams RJ, Ohene-Frempong K, Wang W (2001). "Sickle cell and the brain". Hematology. American Society of Hematology. Education Program. 2001 (1): 31–46. doi:10.1182/asheducation-2001.1.31. PMID 11722977.
Adams RJ (November 2007). "Big strokes in small persons". Archives of Neurology. 64 (11): 1567–1574. doi:10.1001/archneur.64.11.1567. PMID 17998439.
Martí-Carvajal AJ, Solà I, Agreda-Pérez LH (December 2019). "Treatment for avascular necrosis of bone in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 2019 (12): CD004344. doi:10.1002/14651858.CD004344.pub7. PMC 6894369. PMID 31803937.
Chrouser KL, Ajiboye OB, Oyetunji TA, Chang DC (April 2011). "Priapism in the United States: the changing role of sickle cell disease". American Journal of Surgery. 201 (4): 468–474. doi:10.1016/j.amjsurg.2010.03.017. PMID 21421100.
Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, et al. (October 1991). "Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality". Annals of Internal Medicine. 115 (8): 614–620. doi:10.7326/0003-4819-115-8-614. PMID 1892333.
Saborio P, Scheinman JI (January 1999). "Sickle Cell Nephropathy". Journal of the American Society of Nephrology. 10 (1): 187–192. doi:10.1681/ASN.V101187. ISSN 1046-6673. PMID 9890326.
Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK (October 2010). "Leg ulcers in sickle cell disease". American Journal of Hematology. 85 (10): 831–833. doi:10.1002/ajh.21838. ISSN 0361-8609. PMC 2953786. PMID 20872960.
Elagouz M, Jyothi S, Gupta B, Sivaprasad S (July 2010). "Sickle cell disease and the eye: old and new concepts". Survey of Ophthalmology. 55 (4): 359–377. doi:10.1016/j.survophthal.2009.11.004. PMID 20452638.
Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. (January 2008). "Daily assessment of pain in adults with sickle cell disease". Annals of Internal Medicine. 148 (2): 94–101. CiteSeerX 10.1.1.690.5870. doi:10.7326/0003-4819-148-2-200801150-00004. PMID 18195334. S2CID 34924760.
Lai YC, Potoka KC, Champion HC, Mora AL, Gladwin MT (June 2014). "Pulmonary arterial hypertension: the clinical syndrome". Circulation Research. 115 (1): 115–130. doi:10.1161/CIRCRESAHA.115.301146. PMC 4096686. PMID 24951762.
Caughey MC, Poole C, Ataga KI, Hinderliter AL (August 2015). "Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review". British Journal of Haematology. 170 (3): 416–424. doi:10.1111/bjh.13447. PMID 25854714. S2CID 23920740.
Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, et al. (March 2016). "Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease". JACC. Cardiovascular Imaging. 9 (3): 243–252. doi:10.1016/j.jcmg.2015.05.013. PMC 4788530. PMID 26897687.
Niss O, Fleck R, Makue F, Alsaied T, Desai P, Towbin JA, et al. (July 2017). "Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia". Blood. 130 (2): 205–213. doi:10.1182/blood-2017-02-767624. PMC 5510791. PMID 28507082.
Rai P, Niss O, Malik P (November 2017). "A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia". Pediatric Blood & Cancer. 64 (11): e26607. doi:10.1002/pbc.26607. PMID 28453224. S2CID 24444332.
Farid Y, Lecat P (2019), "Biochemistry, Hemoglobin Synthesis", StatPearls, StatPearls Publishing, PMID 30725597, retrieved 10 April 2019
Sankaran VG, Orkin SH (January 2013). "The switch from fetal to adult hemoglobin". Cold Spring Harbor Perspectives in Medicine. 3 (1): a011643. doi:10.1101/cshperspect.a011643. PMC 3530042. PMID 23209159.
Green NS, Fabry ME, Kaptue-Noche L, Nagel RL (October 1993). "Senegal haplotype is associated with higher HbF than Benin and Cameroon haplotypes in African children with sickle cell anemia". American Journal of Hematology. 44 (2): 145–146. doi:10.1002/ajh.2830440214. PMID 7505527. S2CID 27341091.
Inusa BP, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, et al. (June 2019). "Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment". International Journal of Neonatal Screening. 5 (2): 20. doi:10.3390/ijns5020020. ISSN 2409-515X. PMC 7510211. PMID 33072979.
Odièvre MH, Verger E, Silva-Pinto AC, Elion J (October 2011). "Pathophysiological insights in sickle cell disease". The Indian Journal of Medical Research. 134 (1): 532–537. doi:10.1007/bf00168807. PMC 3237253. PMID 22089617.
Uyoga S, Olupot-Olupot P, Connon R, Kiguli S, Opoka RO, Alaroker F, et al. (September 2022). "Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT)". The Lancet Child & Adolescent Health. 6 (9): 606–613. doi:10.1016/s2352-4642(22)00153-5. ISSN 2352-4642. PMC 7613576. PMID 35785794.
Luzzatto L (3 October 2012). "Sickle Cell Anaemia and Malaria". Mediterranean Journal of Hematology and Infectious Diseases. 4 (1): e2012065. doi:10.4084/mjhid.2012.065. ISSN 2035-3006. PMC 3499995. PMID 23170194.
Kwiatkowski DP (August 2005). "How malaria has affected the human genome and what human genetics can teach us about malaria". American Journal of Human Genetics. 77 (2): 171–192. doi:10.1086/432519. PMC 1224522. PMID 16001361.
Ponçon N, Toty C, L'Ambert G, Le Goff G, Brengues C, Schaffner F, et al. (February 2007). "Biology and dynamics of potential malaria vectors in Southern France". Malaria Journal. 6 (1): 18. doi:10.1186/1475-2875-6-18. PMC 1808464. PMID 17313664.
Arif SH (19 March 2008). "Sickle cell disease and malaria". Indian Journal of Hematology & Blood Transfusion. 23 (3–4): 70–72. doi:10.1007/s12288-008-0001-3. PMC 3453113. PMID 23100918.
Cao H, Antonopoulos A, Henderson S, Wassall H, Brewin J, Masson A, et al. (19 March 2021). "Red blood cell mannoses as phagocytic ligands mediating both sickle cell anaemia and malaria resistance". Nature Communications. 12 (1): 1792. Bibcode:2021NatCo..12.1792C. doi:10.1038/s41467-021-21814-z. ISSN 2041-1723. PMC 7979802. PMID 33741926.
Padilla F, Bromberg PA, Jensen WN (1 May 1973). "The Sickle-Unsickle Cycle: A Cause of Cell Fragmentation Leading to Permanently Deformed Cells". Blood. 41 (5): 653–660. doi:10.1182/blood.V41.5.653.653. ISSN 0006-4971. PMID 4694082.
Gbotosho OT, Kapetanaki MG, Kato GJ (27 January 2021). "The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease". Frontiers in Immunology. 11. doi:10.3389/fimmu.2020.561917. ISSN 1664-3224. PMC 7873693. PMID 33584641.
Sundd P, Gladwin MT, Novelli EM (24 January 2019). "Pathophysiology of Sickle Cell Disease". Annual Review of Pathology: Mechanisms of Disease. 14 (1): 263–292. doi:10.1146/annurev-pathmechdis-012418-012838. ISSN 1553-4006. PMC 7053558. PMID 30332562.
Arishi WA, Alhadrami HA, Zourob M (5 May 2021). "Techniques for the Detection of Sickle Cell Disease: A Review". Micromachines. 12 (5): 519. doi:10.3390/mi12050519. PMC 8148117. PMID 34063111.
Mendez-Marti SR, Zik C, Alan S, Wang H, Ershler WB (June 2024). "Sickle Cell Screening in Adults: A Current Review of Point-of-Care Testing". Journal of Hematology. 13 (3): 53–60. doi:10.14740/jh1272. ISSN 1927-1212. PMC 11236353. PMID 38993742.
Garfin DE (1990), Deutscher MP (ed.), "[35] Isoelectric focusing", Methods in Enzymology, Guide to Protein Purification, 182, Academic Press: 459–477, doi:10.1016/0076-6879(90)82037-3, ISBN 978-0-12-182083-1, PMID 2314254, retrieved 20 November 2024
Dixit R, Nettem S, Madan SS, Soe HH, Abas AB, Vance LD, et al. (March 2018). "Folate supplementation in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 3 (4): CD011130. doi:10.1002/14651858.CD011130.pub3. PMC 5440187. PMID 29546732.
Obeagu EI, Obeagu GU (20 September 2024). "Immunization strategies for individuals with sickle cell anemia: A narrative review". Medicine. 103 (38): e39756. doi:10.1097/MD.0000000000039756. PMC 11419550. PMID 39312357.
Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, et al. (April 2003). "Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment". The Journal of the American Medical Association. 289 (13): 1645–1651. doi:10.1001/jama.289.13.1645. PMID 12672732.
Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. (May 1995). "Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia". The New England Journal of Medicine. 332 (20): 1317–1322. doi:10.1056/NEJM199505183322001. PMID 7715639.
McGann P, Ware R (14 September 2015). "Hydroxyurea therapy for sickle cell anemia". Expert Opinion in Drug Safety. 14 (11): 1749–1758. doi:10.1517/14740338.2015.1088827. PMC 5868345. PMID 26366626.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. (September 2014). "Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members". The Journal of the American Medical Association. 312 (10): 1033–1048. doi:10.1001/jama.2014.10517. PMID 25203083. S2CID 37681044.
Platt OS (March 2008). "Hydroxyurea for the treatment of sickle cell anemia". The New England Journal of Medicine. 358 (13): 1362–1369. doi:10.1056/NEJMct0708272. PMID 18367739. S2CID 351061.
Rankine-Mullings AE, Nevitt SJ (September 2022). "Hydroxyurea (hydroxycarbamide) for sickle cell disease". The Cochrane Database of Systematic Reviews. 2022 (10): CD002202. doi:10.1002/14651858.CD002202.pub3. PMC 9435593. PMID 36047926.
Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, et al. (August 2019). "A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease". The New England Journal of Medicine. 381 (6): 509–519. doi:10.1056/NEJMoa1903212. PMID 31199090.
Han H, Hensch L, Tubman VN (10 December 2021). "Indications for transfusion in the management of sickle cell disease". Hematology. 2021 (1): 696–703. doi:10.1182/hematology.2021000307. ISSN 1520-4391. PMC 8791131. PMID 34889416.
Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. (July 1998). "Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography". The New England Journal of Medicine. 339 (1): 5–11. doi:10.1056/NEJM199807023390102. PMID 9647873.
Gyang E, Yeom K, Hoppe C, Partap S, Jeng M (January 2011). "Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease". American Journal of Hematology. 86 (1): 104–106. doi:10.1002/ajh.21901. PMID 21117059.
Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, et al. (March 2010). "Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease". European Journal of Haematology. 84 (3): 259–265. doi:10.1111/j.1600-0609.2009.01379.x. PMID 19912310. S2CID 24316310.
Friend A, Settelmeyer TP, Girzadas D (2024), "Acute Chest Syndrome", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28722902, retrieved 6 December 2024
Anie KA, Green J (May 2015). "Psychological therapies for sickle cell disease and pain". The Cochrane Database of Systematic Reviews. 2015 (5): CD001916. doi:10.1002/14651858.CD001916.pub3. PMC 7063720. PMID 25966336.
Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, et al. (August 1996). "Bone marrow transplantation for sickle cell disease". The New England Journal of Medicine. 335 (6): 369–376. doi:10.1056/NEJM199608083350601. PMID 8663884. S2CID 25256772.
Olson TS, Walters MC (1 October 2023). "Allogeneic haematopoietic stem-cell transplantation versus gene therapy for haemoglobinopathies". The Lancet Haematology. 10 (10): e798 – e800. doi:10.1016/S2352-3026(23)00246-6. ISSN 2352-3026. PMID 37793770.
Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, et al. (2 March 2017). "Gene Therapy in a Patient with Sickle Cell Disease". New England Journal of Medicine. 376 (9): 848–855. doi:10.1056/NEJMoa1609677. ISSN 0028-4793. PMID 28249145.
Rotin LE, Viswabandya A, Kumar R, Patriquin CJ, Kuo KH (31 December 2023). "A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease". Hematology. 28 (1). doi:10.1080/16078454.2022.2163357. ISSN 1607-8454. PMID 36728286.
Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN (1 December 2011). "Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality". American Journal of Preventive Medicine. 41 (6): S398 – S405. doi:10.1016/j.amepre.2011.09.013. ISSN 0749-3797. PMC 3708126. PMID 22099364.
Weatherall DJ, Clegg JB (2001). "Inherited haemoglobin disorders: an increasing global health problem". Bulletin of the World Health Organization. 79 (8): 704–712. PMC 2566499. PMID 11545326.
Roberts I, de Montalembert M (July 2007). "Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe". Haematologica. 92 (7): 865–871. doi:10.3324/haematol.11474. PMID 17606434.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Wellems TE, Hayton K, Fairhurst RM (September 2009). "The impact of malaria parasitism: from corpuscles to communities". The Journal of Clinical Investigation. 119 (9): 2496–2505. doi:10.1172/JCI38307. PMC 2735907. PMID 19729847.
Tusuubira SK, Nakayinga R, Mwambi B, Odda J, Kiconco S, Komuhangi A (April 2018). "Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda". BMC Public Health. 18 (1): 561. doi:10.1186/s12889-018-5496-4. PMC 5924488. PMID 29703184.
Ndeezi G, Kiyaga C, Hernandez AG, Munube D, Howard TA, Ssewanyana I, et al. (March 2016). "Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study". The Lancet. Global Health. 4 (3): e195 – e200. doi:10.1016/S2214-109X(15)00288-0. PMID 26833239.
Edwards QT, Seibert D, Macri C, Covington C, Tilghman J (November 2004). "Assessing ethnicity in preconception counseling: genetics—what nurse practitioners need to know". Journal of the American Academy of Nurse Practitioners. 16 (11): 472–480. doi:10.1111/j.1745-7599.2004.tb00426.x. PMID 15617360. S2CID 7644129.
Vlachadis N, Vrachnis N (15 November 2022). "A Review of Sickle Cell Disease". JAMA. 328 (19): 1979. doi:10.1001/jama.2022.16732. ISSN 0098-7484. PMID 36378213.
Bardakdjian J, Wajcman H (September 2004). "[Epidemiology of sickle cell anemia]". La Revue du Praticien (in French). 54 (14): 1531–1533. PMID 15558961.
Beillat M, Durand-Zaleski I, Pirenne F, Bénard S, Chillotti L, Galacteros F (21 September 2023). "Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires". Frontiers in Public Health. 11: 1215605. doi:10.3389/fpubh.2023.1215605. PMC 10552641. PMID 37808997.
Thuret I, Sarles J, Merono F, Suzineau E, Collomb J, Lena-Russo D, et al. (June 2010). "Neonatal screening for sickle cell disease in France: evaluation of the selective process". Journal of Clinical Pathology. 63 (6): 548–551. doi:10.1136/jcp.2009.068874. PMID 20498028. S2CID 22391674.
Jastaniah W (2011). "Epidemiology of sickle cell disease in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 289–293. doi:10.4103/0256-4947.81540. PMC 3119971. PMID 21623060.
Memish ZA, Saeedi MY (2011). "Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 229–235. doi:10.4103/0256-4947.81527. PMC 3119961. PMID 21623050.
Al Arrayed S, Al Hajeri A (2010). "Public awareness of sickle cell disease in Bahrain". Annals of Saudi Medicine. 30 (4): 284–288. doi:10.4103/0256-4947.65256. PMC 2931779. PMID 20622345.
Asnani MR, McCaw-Binns AM, Reid ME (2011). "Excess risk of maternal death from sickle cell disease in Jamaica: 1998–2007". PLOS ONE. 6 (10): e26281. Bibcode:2011PLoSO...626281A. doi:10.1371/journal.pone.0026281. PMC 3200316. PMID 22039456.
Ballas SK, Gupta K, Adams-Graves P (November 2012). "Sickle cell pain: a critical reappraisal". Blood. 120 (18): 3647–3656. doi:10.1182/blood-2012-04-383430. PMID 22923496.
Herrick JB (1 November 1910). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia". Archives of Internal Medicine. 6 (5): 179–184. doi:10.1001/archinte.1910.00050330050003.; reprinted as Herrick JB (2001). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910". The Yale Journal of Biology and Medicine. 74 (3): 179–184. PMC 2588723. PMID 11501714.
Mason VR (1922). "Sickle cell anemia". The Journal of the American Medical Association. 79 (16): 1318–1320. doi:10.1001/jama.1922.02640160038012. Reprinted in Mason VR (October 1985). "Landmark article Oct. 14, 1922: Sickle cell anemia. By V.R. Mason". The Journal of the American Medical Association. 254 (14): 1955–1957. doi:10.1001/jama.254.14.1955. PMID 3900438.
Pauling L, Itano HA (November 1949). "Sickle cell anemia a molecular disease". Science. 110 (2865): 543–548. Bibcode:1949Sci...110..543P. doi:10.1126/science.110.2865.543. PMID 15395398. S2CID 31674765.
Ingram VM (October 1956). "A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin". Nature. 178 (4537): 792–794. Bibcode:1956Natur.178..792I. doi:10.1038/178792a0. PMID 13369537. S2CID 4167855.
Richard-Lenoble D, Toublanc JE, Zinsou RD, Kombila M, Carme B (1980). "[Results of a systematic study of drepanocytosis in 1,500 Gabonese using hemoglobin electrophoresis]" [Results of a systematic study of drepanocytosis in 1,500 Gabonese using hemoglobin electrophoresis]. Bulletin de la Société de Pathologie Exotique et de ses Filiales (in French). 73 (2): 200–206. PMID 7460122.
Srikanthan S (2023). "Contested Disability: Sickle Cell Disease". Health & Social Work. 48 (3): 209–216. doi:10.1093/hsw/hlad014. PMID 37315205.
Bulgin D, Tanabe P, Jenerette C (August 2018). "Stigma of Sickle Cell Disease: A Systematic Review". Issues in Mental Health Nursing. 39 (8): 675–686. doi:10.1080/01612840.2018.1443530. PMC 6186193. PMID 29652215.
Tusuubira SK, Naggawa T, Nakamoga V (October 2019). "To Join Or Not To Join? A Case Of Sickle Cell Clubs, Stigma And Discrimination In Secondary Schools In Butambala District, Uganda". Adolescent Health, Medicine and Therapeutics. 10: 145–152. doi:10.2147/AHMT.S223956. PMC 6778728. PMID 31632168.
Okwi AL, Byarugaba W, Ndugwa CM, Parkes A, Ocaido M, Tumwine JK (September 2009). "Knowledge gaps, attitude and beliefs of the communities about sickle cell disease in Eastern and Western Uganda". East African Medical Journal. 86 (9): 442–449. doi:10.4314/eamj.v86i9.54167. PMID 21644415.
Marsh VM, Kamuya DM, Molyneux SS (August 2011). "'All her children are born that way': gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya". Ethnicity & Health. 16 (4–5): 343–359. doi:10.1080/13557858.2010.541903. PMC 3534410. PMID 21797722.
Sehlo MG, Kamfar HZ (April 2015). "Depression and quality of life in children with sickle cell disease: the effect of social support". BMC Psychiatry. 15 (1): 78. doi:10.1186/s12888-015-0461-6. PMC 4394397. PMID 25880537.

ncbi.nlm.nih.gov

Thomson AM, McHugh TA, Oron AP, Teply C, Lonberg N, Vilchis Tella V, et al. (August 2023). "Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021". The Lancet. Haematology. 10 (8): e585 – e599. doi:10.1016/S2352-3026(23)00118-7. ISSN 2352-3026. PMC 10390339. PMID 37331373.{{cite journal}}: CS1 maint: overridden setting (link)
Singh A, Irfan H, Fatima E, Nazir Z, Verma A, Akilimali A (15 May 2024). "Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease". Annals of Medicine and Surgery. 86 (8): 4555. doi:10.1097/MS9.0000000000002146. PMC 11305803. PMID 39118728.
Shah P, Khaleel M, Thuptimdang W, Sunwoo J, Veluswamy S, Chalacheva P, et al. (1 January 2020). "Mental stress causes vasoconstriction in subjects with sickle cell disease and in normal controls". Haematologica. 105 (1): 83–90. doi:10.3324/haematol.2018.211391. ISSN 1592-8721. PMC 6939522. PMID 30975906.
Kane I, Kumar A, Atalla E, Nagalli S (5 June 2023), "Splenic Sequestration Crisis", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31985957, retrieved 28 October 2024
Friend A, Settelmeyer TP, Girzadas D (25 November 2023), "Acute Chest Syndrome", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28722902, retrieved 27 October 2024
Martí-Carvajal AJ, Solà I, Agreda-Pérez LH (December 2019). "Treatment for avascular necrosis of bone in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 2019 (12): CD004344. doi:10.1002/14651858.CD004344.pub7. PMC 6894369. PMID 31803937.
Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK (October 2010). "Leg ulcers in sickle cell disease". American Journal of Hematology. 85 (10): 831–833. doi:10.1002/ajh.21838. ISSN 0361-8609. PMC 2953786. PMID 20872960.
Lai YC, Potoka KC, Champion HC, Mora AL, Gladwin MT (June 2014). "Pulmonary arterial hypertension: the clinical syndrome". Circulation Research. 115 (1): 115–130. doi:10.1161/CIRCRESAHA.115.301146. PMC 4096686. PMID 24951762.
Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, et al. (March 2016). "Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease". JACC. Cardiovascular Imaging. 9 (3): 243–252. doi:10.1016/j.jcmg.2015.05.013. PMC 4788530. PMID 26897687.
Niss O, Fleck R, Makue F, Alsaied T, Desai P, Towbin JA, et al. (July 2017). "Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia". Blood. 130 (2): 205–213. doi:10.1182/blood-2017-02-767624. PMC 5510791. PMID 28507082.
Farid Y, Lecat P (2019), "Biochemistry, Hemoglobin Synthesis", StatPearls, StatPearls Publishing, PMID 30725597, retrieved 10 April 2019
Sankaran VG, Orkin SH (January 2013). "The switch from fetal to adult hemoglobin". Cold Spring Harbor Perspectives in Medicine. 3 (1): a011643. doi:10.1101/cshperspect.a011643. PMC 3530042. PMID 23209159.
Inusa BP, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, et al. (June 2019). "Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment". International Journal of Neonatal Screening. 5 (2): 20. doi:10.3390/ijns5020020. ISSN 2409-515X. PMC 7510211. PMID 33072979.
Odièvre MH, Verger E, Silva-Pinto AC, Elion J (October 2011). "Pathophysiological insights in sickle cell disease". The Indian Journal of Medical Research. 134 (1): 532–537. doi:10.1007/bf00168807. PMC 3237253. PMID 22089617.
Uyoga S, Olupot-Olupot P, Connon R, Kiguli S, Opoka RO, Alaroker F, et al. (September 2022). "Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT)". The Lancet Child & Adolescent Health. 6 (9): 606–613. doi:10.1016/s2352-4642(22)00153-5. ISSN 2352-4642. PMC 7613576. PMID 35785794.
Luzzatto L (3 October 2012). "Sickle Cell Anaemia and Malaria". Mediterranean Journal of Hematology and Infectious Diseases. 4 (1): e2012065. doi:10.4084/mjhid.2012.065. ISSN 2035-3006. PMC 3499995. PMID 23170194.
Kwiatkowski DP (August 2005). "How malaria has affected the human genome and what human genetics can teach us about malaria". American Journal of Human Genetics. 77 (2): 171–192. doi:10.1086/432519. PMC 1224522. PMID 16001361.
Ponçon N, Toty C, L'Ambert G, Le Goff G, Brengues C, Schaffner F, et al. (February 2007). "Biology and dynamics of potential malaria vectors in Southern France". Malaria Journal. 6 (1): 18. doi:10.1186/1475-2875-6-18. PMC 1808464. PMID 17313664.
Arif SH (19 March 2008). "Sickle cell disease and malaria". Indian Journal of Hematology & Blood Transfusion. 23 (3–4): 70–72. doi:10.1007/s12288-008-0001-3. PMC 3453113. PMID 23100918.
Cao H, Antonopoulos A, Henderson S, Wassall H, Brewin J, Masson A, et al. (19 March 2021). "Red blood cell mannoses as phagocytic ligands mediating both sickle cell anaemia and malaria resistance". Nature Communications. 12 (1): 1792. Bibcode:2021NatCo..12.1792C. doi:10.1038/s41467-021-21814-z. ISSN 2041-1723. PMC 7979802. PMID 33741926.
Gbotosho OT, Kapetanaki MG, Kato GJ (27 January 2021). "The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease". Frontiers in Immunology. 11. doi:10.3389/fimmu.2020.561917. ISSN 1664-3224. PMC 7873693. PMID 33584641.
Sundd P, Gladwin MT, Novelli EM (24 January 2019). "Pathophysiology of Sickle Cell Disease". Annual Review of Pathology: Mechanisms of Disease. 14 (1): 263–292. doi:10.1146/annurev-pathmechdis-012418-012838. ISSN 1553-4006. PMC 7053558. PMID 30332562.
Arishi WA, Alhadrami HA, Zourob M (5 May 2021). "Techniques for the Detection of Sickle Cell Disease: A Review". Micromachines. 12 (5): 519. doi:10.3390/mi12050519. PMC 8148117. PMID 34063111.
Mendez-Marti SR, Zik C, Alan S, Wang H, Ershler WB (June 2024). "Sickle Cell Screening in Adults: A Current Review of Point-of-Care Testing". Journal of Hematology. 13 (3): 53–60. doi:10.14740/jh1272. ISSN 1927-1212. PMC 11236353. PMID 38993742.
Petrou M (2013), "GENETIC COUNSELLING", Prevention of Thalassaemias and Other Haemoglobin Disorders: Volume 1: Principles [Internet]. 2nd edition, Thalassaemia International Federation, retrieved 22 November 2024
Dixit R, Nettem S, Madan SS, Soe HH, Abas AB, Vance LD, et al. (March 2018). "Folate supplementation in people with sickle cell disease". The Cochrane Database of Systematic Reviews. 3 (4): CD011130. doi:10.1002/14651858.CD011130.pub3. PMC 5440187. PMID 29546732.
Obeagu EI, Obeagu GU (20 September 2024). "Immunization strategies for individuals with sickle cell anemia: A narrative review". Medicine. 103 (38): e39756. doi:10.1097/MD.0000000000039756. PMC 11419550. PMID 39312357.
McGann P, Ware R (14 September 2015). "Hydroxyurea therapy for sickle cell anemia". Expert Opinion in Drug Safety. 14 (11): 1749–1758. doi:10.1517/14740338.2015.1088827. PMC 5868345. PMID 26366626.
Rankine-Mullings AE, Nevitt SJ (September 2022). "Hydroxyurea (hydroxycarbamide) for sickle cell disease". The Cochrane Database of Systematic Reviews. 2022 (10): CD002202. doi:10.1002/14651858.CD002202.pub3. PMC 9435593. PMID 36047926.
Han H, Hensch L, Tubman VN (10 December 2021). "Indications for transfusion in the management of sickle cell disease". Hematology. 2021 (1): 696–703. doi:10.1182/hematology.2021000307. ISSN 1520-4391. PMC 8791131. PMID 34889416.
Friend A, Settelmeyer TP, Girzadas D (2024), "Acute Chest Syndrome", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28722902, retrieved 6 December 2024
Anie KA, Green J (May 2015). "Psychological therapies for sickle cell disease and pain". The Cochrane Database of Systematic Reviews. 2015 (5): CD001916. doi:10.1002/14651858.CD001916.pub3. PMC 7063720. PMID 25966336.
Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN (1 December 2011). "Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality". American Journal of Preventive Medicine. 41 (6): S398 – S405. doi:10.1016/j.amepre.2011.09.013. ISSN 0749-3797. PMC 3708126. PMID 22099364.
Weatherall DJ, Clegg JB (2001). "Inherited haemoglobin disorders: an increasing global health problem". Bulletin of the World Health Organization. 79 (8): 704–712. PMC 2566499. PMID 11545326.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Wellems TE, Hayton K, Fairhurst RM (September 2009). "The impact of malaria parasitism: from corpuscles to communities". The Journal of Clinical Investigation. 119 (9): 2496–2505. doi:10.1172/JCI38307. PMC 2735907. PMID 19729847.
Tusuubira SK, Nakayinga R, Mwambi B, Odda J, Kiconco S, Komuhangi A (April 2018). "Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda". BMC Public Health. 18 (1): 561. doi:10.1186/s12889-018-5496-4. PMC 5924488. PMID 29703184.
Beillat M, Durand-Zaleski I, Pirenne F, Bénard S, Chillotti L, Galacteros F (21 September 2023). "Prevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires". Frontiers in Public Health. 11: 1215605. doi:10.3389/fpubh.2023.1215605. PMC 10552641. PMID 37808997.
Jastaniah W (2011). "Epidemiology of sickle cell disease in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 289–293. doi:10.4103/0256-4947.81540. PMC 3119971. PMID 21623060.
Memish ZA, Saeedi MY (2011). "Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia". Annals of Saudi Medicine. 31 (3): 229–235. doi:10.4103/0256-4947.81527. PMC 3119961. PMID 21623050.
Al Arrayed S, Al Hajeri A (2010). "Public awareness of sickle cell disease in Bahrain". Annals of Saudi Medicine. 30 (4): 284–288. doi:10.4103/0256-4947.65256. PMC 2931779. PMID 20622345.
Asnani MR, McCaw-Binns AM, Reid ME (2011). "Excess risk of maternal death from sickle cell disease in Jamaica: 1998–2007". PLOS ONE. 6 (10): e26281. Bibcode:2011PLoSO...626281A. doi:10.1371/journal.pone.0026281. PMC 3200316. PMID 22039456.
Herrick JB (1 November 1910). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia". Archives of Internal Medicine. 6 (5): 179–184. doi:10.1001/archinte.1910.00050330050003.; reprinted as Herrick JB (2001). "Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910". The Yale Journal of Biology and Medicine. 74 (3): 179–184. PMC 2588723. PMID 11501714.
Bulgin D, Tanabe P, Jenerette C (August 2018). "Stigma of Sickle Cell Disease: A Systematic Review". Issues in Mental Health Nursing. 39 (8): 675–686. doi:10.1080/01612840.2018.1443530. PMC 6186193. PMID 29652215.
Tusuubira SK, Naggawa T, Nakamoga V (October 2019). "To Join Or Not To Join? A Case Of Sickle Cell Clubs, Stigma And Discrimination In Secondary Schools In Butambala District, Uganda". Adolescent Health, Medicine and Therapeutics. 10: 145–152. doi:10.2147/AHMT.S223956. PMC 6778728. PMID 31632168.
Marsh VM, Kamuya DM, Molyneux SS (August 2011). "'All her children are born that way': gendered experiences of stigma in families affected by sickle cell disorder in rural Kenya". Ethnicity & Health. 16 (4–5): 343–359. doi:10.1080/13557858.2010.541903. PMC 3534410. PMID 21797722.
Sehlo MG, Kamfar HZ (April 2015). "Depression and quality of life in children with sickle cell disease: the effect of social support". BMC Psychiatry. 15 (1): 78. doi:10.1186/s12888-015-0461-6. PMC 4394397. PMID 25880537.

nhlbi.nih.gov

"Sickle Cell Disease - Symptoms". National Heart, Lung, and Blood Institute. 20 August 2024. Retrieved 26 October 2024.
"What Is Sickle Cell Disease?". National Heart, Lung, and Blood Institute. 30 September 2024. Retrieved 26 October 2024.
"Sickle Cell Disease - Causes and Risk Factors". National Heart, Lung, and Blood Institute. 20 August 2024. Retrieved 26 October 2024.
"Sickle Cell Disease - Diagnosis". National Heart, Lung, and Blood Institute. 9 September 2024. Retrieved 26 October 2024.
"Sickle Cell Disease - Treatment". National Heart, Lung, and Blood Institute. 30 September 2024. Retrieved 26 October 2024.
"Sickle Cell Disease - How Sickle Cell Disease May Affect Your Health". www.nhlbi.nih.gov. National Heart, Lung, and Blood Institute. 23 April 2024. Retrieved 25 July 2024.
National Heart, Lung and Blood Institute. "Sickle cell anemia, key points". Archived from the original on 2 December 2010. Retrieved 27 November 2010.

npr.org

"Sickle Cell Patients Endure Discrimination, Poor Care And Shortened Lives". NPR.org. 4 November 2017. Retrieved 12 November 2017.

nsgc.org

"National Society of Genetic Counselors : About Genetic Counselors". www.nsgc.org. Retrieved 24 February 2021.

nytimes.com

Kolata G, Holston K (21 October 2024). "Life Without Sickle Cell Beckons Boy Who Completed Gene Therapy". The New York Times.

oup.com

academic.oup.com

Srikanthan S (2023). "Contested Disability: Sickle Cell Disease". Health & Social Work. 48 (3): 209–216. doi:10.1093/hsw/hlad014. PMID 37315205.

psu.edu

citeseerx.ist.psu.edu

Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. (January 2008). "Daily assessment of pain in adults with sickle cell disease". Annals of Internal Medicine. 148 (2): 94–101. CiteSeerX 10.1.1.690.5870. doi:10.7326/0003-4819-148-2-200801150-00004. PMID 18195334. S2CID 34924760.

rarediseases.org

"Sickle Cell Disease". NORD (National Organization for Rare Disorders). Retrieved 10 June 2019.

rwt.nhs.uk

Department of Clinical Illustration, New Cross Hospital, Wolverhampton (8 July 2024). "Vaccination advice for people with Sickle Cell Disorders" (PDF). The Royal Wolverhampton NHS Trust. Retrieved 3 December 2024.{{cite web}}: CS1 maint: multiple names: authors list (link)

science.org

Kaiser J (5 December 2020). "CRISPR and another genetic strategy fix cell defects in two common blood disorders". ScienceMag.org. Science. Retrieved 7 December 2020. ... teams report that two strategies for directly fixing malfunctioning blood cells have dramatically improved the health of a handful of people with these genetic diseases.

screening.nhs.uk

sct.screening.nhs.uk

"Who is offered screening and when?". screening.nhs.uk. Archived from the original on 31 December 2014.

semanticscholar.org

api.semanticscholar.org

Wilkinson E (16 November 2023). "UK regulator approves "groundbreaking" gene treatment for sickle cell and β thalassaemia". BMJ. 383: 2706. doi:10.1136/bmj.p2706. ISSN 1756-1833. PMID 37973171. S2CID 265264939.
Rees DC, Williams TN, Gladwin MT (December 2010). "Sickle-cell disease". Lancet. 376 (9757): 2018–2031. doi:10.1016/s0140-6736(10)61029-x. PMID 21131035. S2CID 29909566.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. (September 2014). "Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members". The Journal of the American Medical Association. 312 (10): 1033–1048. doi:10.1001/jama.2014.10517. PMID 25203083. S2CID 37681044.
Brousse V, Buffet P, Rees D (1 July 2014). "The spleen and sickle cell disease: the sick(led) spleen". British Journal of Haematology. 166 (2): 165–176. doi:10.1111/bjh.12950. ISSN 1365-2141. PMID 24862308. S2CID 40448991.
Paul RN, Castro OL, Aggarwal A, Oneal PA (September 2011). "Acute chest syndrome: sickle cell disease". European Journal of Haematology. 87 (3): 191–207. doi:10.1111/j.1600-0609.2011.01647.x. PMID 21615795. S2CID 40320701.
Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ (December 2011). "Management of children with sickle cell disease: a comprehensive review of the literature". Pediatrics. 128 (6): e1552 – e1574. doi:10.1542/peds.2010-3686. PMID 22123880. S2CID 14524078. Archived from the original on 4 March 2016.
Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. (January 2008). "Daily assessment of pain in adults with sickle cell disease". Annals of Internal Medicine. 148 (2): 94–101. CiteSeerX 10.1.1.690.5870. doi:10.7326/0003-4819-148-2-200801150-00004. PMID 18195334. S2CID 34924760.
Caughey MC, Poole C, Ataga KI, Hinderliter AL (August 2015). "Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review". British Journal of Haematology. 170 (3): 416–424. doi:10.1111/bjh.13447. PMID 25854714. S2CID 23920740.
Rai P, Niss O, Malik P (November 2017). "A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia". Pediatric Blood & Cancer. 64 (11): e26607. doi:10.1002/pbc.26607. PMID 28453224. S2CID 24444332.
Green NS, Fabry ME, Kaptue-Noche L, Nagel RL (October 1993). "Senegal haplotype is associated with higher HbF than Benin and Cameroon haplotypes in African children with sickle cell anemia". American Journal of Hematology. 44 (2): 145–146. doi:10.1002/ajh.2830440214. PMID 7505527. S2CID 27341091.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, et al. (September 2014). "Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members". The Journal of the American Medical Association. 312 (10): 1033–1048. doi:10.1001/jama.2014.10517. PMID 25203083. S2CID 37681044.
Platt OS (March 2008). "Hydroxyurea for the treatment of sickle cell anemia". The New England Journal of Medicine. 358 (13): 1362–1369. doi:10.1056/NEJMct0708272. PMID 18367739. S2CID 351061.
Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, et al. (March 2010). "Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease". European Journal of Haematology. 84 (3): 259–265. doi:10.1111/j.1600-0609.2009.01379.x. PMID 19912310. S2CID 24316310.
Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, et al. (August 1996). "Bone marrow transplantation for sickle cell disease". The New England Journal of Medicine. 335 (6): 369–376. doi:10.1056/NEJM199608083350601. PMID 8663884. S2CID 25256772.
Edwards QT, Seibert D, Macri C, Covington C, Tilghman J (November 2004). "Assessing ethnicity in preconception counseling: genetics—what nurse practitioners need to know". Journal of the American Academy of Nurse Practitioners. 16 (11): 472–480. doi:10.1111/j.1745-7599.2004.tb00426.x. PMID 15617360. S2CID 7644129.
Thuret I, Sarles J, Merono F, Suzineau E, Collomb J, Lena-Russo D, et al. (June 2010). "Neonatal screening for sickle cell disease in France: evaluation of the selective process". Journal of Clinical Pathology. 63 (6): 548–551. doi:10.1136/jcp.2009.068874. PMID 20498028. S2CID 22391674.
Pauling L, Itano HA (November 1949). "Sickle cell anemia a molecular disease". Science. 110 (2865): 543–548. Bibcode:1949Sci...110..543P. doi:10.1126/science.110.2865.543. PMID 15395398. S2CID 31674765.
Ingram VM (October 1956). "A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin". Nature. 178 (4537): 792–794. Bibcode:1956Natur.178..792I. doi:10.1038/178792a0. PMID 13369537. S2CID 4167855.

sicklecellsociety.org

"Inheritance of Sickle Cell Anaemia". Sickle Cell Society. Archived from the original on 8 January 2024. Retrieved 8 January 2024.
"Crizanlizumab - end of NHS supply » Sickle Cell Society". Sickle Cell Society. 1 February 2024. Retrieved 5 December 2024.
"Why is Blood from Afro-Caribbean Donors Special?". sicklecellsociety.org. Archived from the original on 30 December 2014.
Rylatt A (7 October 2022). "No-one is Listening" (PDF).

sicklecelluganda.org

"Sickle Cell Association of Uganda". Sickle Cell Association of Uganda. Retrieved 7 April 2021.

ssa.gov

"Social Security Ruling: SSR 2017-3p". U.S. Social Security Administration. Retrieved 15 January 2018.

stanfordchildrens.org

"default – Stanford Children's Health". www.stanfordchildrens.org. Retrieved 14 March 2020.

texas.gov

dshs.texas.gov

"Splenic Sequestration Crisis | Texas DSHS". www.dshs.texas.gov. Retrieved 28 October 2024.

thejh.org

Mendez-Marti SR, Zik C, Alan S, Wang H, Ershler WB (June 2024). "Sickle Cell Screening in Adults: A Current Review of Point-of-Care Testing". Journal of Hematology. 13 (3): 53–60. doi:10.14740/jh1272. ISSN 1927-1212. PMC 11236353. PMID 38993742.

uab.edu

Kanter J. "New Weapons Against A Deadly Disease: Cutting-Edge Gene Therapy Could Deliver Breakthrough For Sickle Cell Disease - Medicine Magazine". The University of Alabama at Birmingham. Retrieved 7 December 2024.

uscrfuganda.org

"Our Vision and Mission – Uganda Sickle Cell Rescue Foundation". 13 May 2017. Retrieved 6 April 2021.
"Background – Uganda Sickle Cell Rescue Foundation". 13 May 2017. Retrieved 6 April 2021.

utah.edu

learn.genetics.utah.edu

"Inheritance Patterns for Single Gene Disorders". learn.genetics.utah.edu. Archived from the original on 1 July 2019. Retrieved 1 July 2019.

virginia.edu

exhibits.hsl.virginia.edu

"UVa Hospital Celebrating 100 Years". University of Virginia. Archived from the original on 31 January 2015. Retrieved 28 January 2015.

voice-online.co.uk

"Better protection and support for people with sickle cell disease". The Voice. October 2022. pp. 16–17. Retrieved 7 October 2022.

web.archive.org

"Sickle-cell disease and other haemoglobin disorders Fact sheet N°308". January 2011. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
"FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease". U.S. Food and Drug Administration (FDA). 8 December 2023. Archived from the original on 8 December 2023. Retrieved 8 December 2023. This article incorporates text from this source, which is in the public domain.
Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ (December 2011). "Management of children with sickle cell disease: a comprehensive review of the literature". Pediatrics. 128 (6): e1552 – e1574. doi:10.1542/peds.2010-3686. PMID 22123880. S2CID 14524078. Archived from the original on 4 March 2016.
"Inheritance of Sickle Cell Anaemia". Sickle Cell Society. Archived from the original on 8 January 2024. Retrieved 8 January 2024.
"Inheritance Patterns for Single Gene Disorders". learn.genetics.utah.edu. Archived from the original on 1 July 2019. Retrieved 1 July 2019.
"How Does Sickle Cell Cause Disease?". Archived from the original on 23 September 2010. Retrieved 27 November 2010.
"Sickle-cell disease and other haemoglobin disorders Fact sheet N°308". January 2011. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
"MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia". Medicines and Healthcare products Regulatory Agency (MHRA) (Press release). 16 November 2023. Archived from the original on 25 November 2023. Retrieved 8 December 2023.
WHO. "Sickle-cell anaemia – Report by the Secretariat" (PDF). Archived from the original (PDF) on 4 January 2011. Retrieved 27 November 2010.
National Heart, Lung and Blood Institute. "Sickle cell anemia, key points". Archived from the original on 2 December 2010. Retrieved 27 November 2010.
"September is Sickle Cell Awareness Month". Centers for Disease Control and Prevention. Archived from the original on 27 September 2010. Retrieved 6 February 2011.
"Disorder Name: Sickle Cell Disease". New Born Screening. Archived from the original on 28 September 2016. Retrieved 11 October 2016.
"Inheriting sickle cell anaemia – Live Well – NHS Choices". www.nhs.uk. 23 October 2017. Archived from the original on 2 December 2014.
"Sickle cell anaemia – NHS Choices". www.nhs.uk. 23 October 2017. Archived from the original on 13 December 2011.
"Who is offered screening and when?". screening.nhs.uk. Archived from the original on 31 December 2014.
"Give Blood – Resources – Sickle Cell and Blood Donation". Give Blood. Archived from the original on 31 December 2014.
"Why is Blood from Afro-Caribbean Donors Special?". sicklecellsociety.org. Archived from the original on 30 December 2014.
Al Arrayed S (1995). "Features of sickle-cell disease in Bahrain". Eastern Mediterranean Health Journal. 1 (1). Archived from the original on 8 October 2016.
"Sickle Cell Anemia". American Society of Hematology. 16 December 2014. Archived from the original on 25 June 2017. Retrieved 1 May 2017.
"Life with sickle cell – Nation – Nepali Times". Archived from the original on 24 June 2015.
"UVa Hospital Celebrating 100 Years". University of Virginia. Archived from the original on 31 January 2015. Retrieved 28 January 2015.
"Foster, Gloria". Facts On File History Database. Archived from the original on 5 March 2016. Retrieved 25 February 2015.

who.int

"Sickle-cell disease and other haemoglobin disorders Fact sheet N°308". January 2011. Archived from the original on 9 March 2016. Retrieved 8 March 2016.
"Sickle-cell disease and other haemoglobin disorders Fact sheet N°308". January 2011. Archived from the original on 9 March 2016. Retrieved 8 March 2016.

apps.who.int

WHO. "Sickle-cell anaemia – Report by the Secretariat" (PDF). Archived from the original (PDF) on 4 January 2011. Retrieved 27 November 2010.

emro.who.int

Al Arrayed S (1995). "Features of sickle-cell disease in Bahrain". Eastern Mediterranean Health Journal. 1 (1). Archived from the original on 8 October 2016.

worldcat.org

search.worldcat.org

Thomson AM, McHugh TA, Oron AP, Teply C, Lonberg N, Vilchis Tella V, et al. (August 2023). "Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021". The Lancet. Haematology. 10 (8): e585 – e599. doi:10.1016/S2352-3026(23)00118-7. ISSN 2352-3026. PMC 10390339. PMID 37331373.{{cite journal}}: CS1 maint: overridden setting (link)
Nelson MD, Bennett DM, Lehman ME, Okonji AI (5 December 2022). "Dizziness, Falls, and Hearing Loss in Adults Living With Sickle Cell Disease". American Journal of Audiology. 31 (4): 1178–1190. doi:10.1044/2022_AJA-22-00059. ISSN 1558-9137. PMID 36251873.
Wilkinson E (16 November 2023). "UK regulator approves "groundbreaking" gene treatment for sickle cell and β thalassaemia". BMJ. 383: 2706. doi:10.1136/bmj.p2706. ISSN 1756-1833. PMID 37973171. S2CID 265264939.
Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. (15 July 1995). "Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease [see comments]". Blood. 86 (2): 776–783. doi:10.1182/blood.v86.2.776.bloodjournal862776. ISSN 0006-4971.
Shah P, Khaleel M, Thuptimdang W, Sunwoo J, Veluswamy S, Chalacheva P, et al. (1 January 2020). "Mental stress causes vasoconstriction in subjects with sickle cell disease and in normal controls". Haematologica. 105 (1): 83–90. doi:10.3324/haematol.2018.211391. ISSN 1592-8721. PMC 6939522. PMID 30975906.
Brousse V, Buffet P, Rees D (1 July 2014). "The spleen and sickle cell disease: the sick(led) spleen". British Journal of Haematology. 166 (2): 165–176. doi:10.1111/bjh.12950. ISSN 1365-2141. PMID 24862308. S2CID 40448991.
Saborio P, Scheinman JI (January 1999). "Sickle Cell Nephropathy". Journal of the American Society of Nephrology. 10 (1): 187–192. doi:10.1681/ASN.V101187. ISSN 1046-6673. PMID 9890326.
Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK (October 2010). "Leg ulcers in sickle cell disease". American Journal of Hematology. 85 (10): 831–833. doi:10.1002/ajh.21838. ISSN 0361-8609. PMC 2953786. PMID 20872960.
Inusa BP, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, et al. (June 2019). "Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment". International Journal of Neonatal Screening. 5 (2): 20. doi:10.3390/ijns5020020. ISSN 2409-515X. PMC 7510211. PMID 33072979.
Uyoga S, Olupot-Olupot P, Connon R, Kiguli S, Opoka RO, Alaroker F, et al. (September 2022). "Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Children Trial (TRACT)". The Lancet Child & Adolescent Health. 6 (9): 606–613. doi:10.1016/s2352-4642(22)00153-5. ISSN 2352-4642. PMC 7613576. PMID 35785794.
Luzzatto L (3 October 2012). "Sickle Cell Anaemia and Malaria". Mediterranean Journal of Hematology and Infectious Diseases. 4 (1): e2012065. doi:10.4084/mjhid.2012.065. ISSN 2035-3006. PMC 3499995. PMID 23170194.
Cao H, Antonopoulos A, Henderson S, Wassall H, Brewin J, Masson A, et al. (19 March 2021). "Red blood cell mannoses as phagocytic ligands mediating both sickle cell anaemia and malaria resistance". Nature Communications. 12 (1): 1792. Bibcode:2021NatCo..12.1792C. doi:10.1038/s41467-021-21814-z. ISSN 2041-1723. PMC 7979802. PMID 33741926.
Padilla F, Bromberg PA, Jensen WN (1 May 1973). "The Sickle-Unsickle Cycle: A Cause of Cell Fragmentation Leading to Permanently Deformed Cells". Blood. 41 (5): 653–660. doi:10.1182/blood.V41.5.653.653. ISSN 0006-4971. PMID 4694082.
Gbotosho OT, Kapetanaki MG, Kato GJ (27 January 2021). "The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease". Frontiers in Immunology. 11. doi:10.3389/fimmu.2020.561917. ISSN 1664-3224. PMC 7873693. PMID 33584641.
Sundd P, Gladwin MT, Novelli EM (24 January 2019). "Pathophysiology of Sickle Cell Disease". Annual Review of Pathology: Mechanisms of Disease. 14 (1): 263–292. doi:10.1146/annurev-pathmechdis-012418-012838. ISSN 1553-4006. PMC 7053558. PMID 30332562.
Mendez-Marti SR, Zik C, Alan S, Wang H, Ershler WB (June 2024). "Sickle Cell Screening in Adults: A Current Review of Point-of-Care Testing". Journal of Hematology. 13 (3): 53–60. doi:10.14740/jh1272. ISSN 1927-1212. PMC 11236353. PMID 38993742.
Han H, Hensch L, Tubman VN (10 December 2021). "Indications for transfusion in the management of sickle cell disease". Hematology. 2021 (1): 696–703. doi:10.1182/hematology.2021000307. ISSN 1520-4391. PMC 8791131. PMID 34889416.
Olson TS, Walters MC (1 October 2023). "Allogeneic haematopoietic stem-cell transplantation versus gene therapy for haemoglobinopathies". The Lancet Haematology. 10 (10): e798 – e800. doi:10.1016/S2352-3026(23)00246-6. ISSN 2352-3026. PMID 37793770.
Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, et al. (2 March 2017). "Gene Therapy in a Patient with Sickle Cell Disease". New England Journal of Medicine. 376 (9): 848–855. doi:10.1056/NEJMoa1609677. ISSN 0028-4793. PMID 28249145.
Rotin LE, Viswabandya A, Kumar R, Patriquin CJ, Kuo KH (31 December 2023). "A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease". Hematology. 28 (1). doi:10.1080/16078454.2022.2163357. ISSN 1607-8454. PMID 36728286.
Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN (1 December 2011). "Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality". American Journal of Preventive Medicine. 41 (6): S398 – S405. doi:10.1016/j.amepre.2011.09.013. ISSN 0749-3797. PMC 3708126. PMID 22099364.
Karkoska K, McGann PT (2 November 2023). "Changing Trends in Sickle Cell Disease-Related Mortality in the United States over Four Decades". Blood. 142 (Supplement 1): 925. doi:10.1182/blood-2023-177988. ISSN 0006-4971.
Vlachadis N, Vrachnis N (15 November 2022). "A Review of Sickle Cell Disease". JAMA. 328 (19): 1979. doi:10.1001/jama.2022.16732. ISSN 0098-7484. PMID 36378213.
Washington HA (2006). Medical apartheid : the dark history of medical experimentation on Black Americans from colonial times to the present (1st paperback ed.). New York: Harlem Moon. ISBN 978-0-7679-1547-2. OCLC 192050177.

zenodo.org

Mason VR (1922). "Sickle cell anemia". The Journal of the American Medical Association. 79 (16): 1318–1320. doi:10.1001/jama.1922.02640160038012. Reprinted in Mason VR (October 1985). "Landmark article Oct. 14, 1922: Sickle cell anemia. By V.R. Mason". The Journal of the American Medical Association. 254 (14): 1955–1957. doi:10.1001/jama.254.14.1955. PMID 3900438.